Please assess the completion status of the following clinical trial:

Trial Title: The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* participants \>/= 18 years of age~* patients for whom POC testing would change their course of treatment (in opinion of treatment team)~Exclusion Criteria:~* patients in whom conventional COVID-19 testing would not have otherwise been performed~* patients in whom immediate COVID-19 testing would not alter short-term treatment~* patients who refuse consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients consulted upon by ICU, internal medicine, or cardiology for hospital admission (Type: EXPERIMENTAL): All patients will have both standard care and point-of-care (experimental) NP swabs performed.
- patients undergoing cardiac testing/procedures (Type: EXPERIMENTAL): All patients will have both standard care and point-of-care (experimental) NP swabs performed.
- patients awaiting surgery (Type: EXPERIMENTAL): All patients will have both standard care and point-of-care (experimental) NP swabs performed.
- Health Care Workers (Type: EXPERIMENTAL): Health Care Workers who are being screened for COVID-19 will have both standard care and point-of-care NP swabs performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).